Brief: Addex Therapeutics Q2 Operating Income CHF -733 Thousand
30/09/2025 06:00
Sep 30 (Reuters) - Addex Therapeutics Q2 EPS CHF -0.02. Q2 net income CHF -1.841 million
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand